The PI3K/AKT/mTOR pathway is activated in most human cancers, increasing the secretion of VEGF through HIF-1-dependent or HIF-1-independent mechanisms and modulating angiogenesis by regulating the expression of NO and angiopoietins [41]. The gene discussed is AKT1; the disease is cancer.